Dr. Lisa Conrad Larkin , MD
Internal Medicine • Cincinnati, OH
3908 Miami Rd
Cincinnati, OH 452273705
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 19, 2005; this date does not establish years in practice.
-
Published CMS data list 1,400 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 110 prescription fills, including refills.
- Losartan Potassium — 99 prescription fills, including refills.
- Metformin Hcl Er (Metformin Hcl) — 88 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 54 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Internal Medicine in Cincinnati, OH (2024, 348 clinicians with data). Median for this group: 1,875. Middle half: 178 to 5,162.
Close to the middle for Part D prescriptions among clinicians listed under Internal Medicine in Ohio (2024, 3,384 clinicians with data). Median for this group: 836. Middle half: 118 to 5,398.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,728 in 2020 to 1,400 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
3908 Miami Rd
Cincinnati, OH 452273705
CMS Doctors and Clinicians lists 1 group name: Kentucky Rehabilitation Services, Inc.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Yale University School Of Medicine
1991
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
3,408 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$135,975 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $69,178.49 across 104 records.
By nature of payment (3 largest of 6)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $41,579.50 across 14 records.
- Consulting Fee: $8,435.00 across 2 records.
- Honoraria: $6,600.00 across 2 records.
Reporting-company totals (3 largest of 22)
- MAYNE PHARMA COMMERCIAL LLC: $45,807.46 across 40 records.
- Bayer Healthcare Pharmaceuticals Inc.: $14,596.31 across 18 records.
- Astellas Pharma US Inc: $7,696.56 across 12 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
35 years (graduated 1991)
CMS Doctors and Clinicians data list 1991 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Can order Medicare-covered services
CMS lists Dr. Larkin as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Cincinnati and Ohio
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Internal Medicine in Cincinnati, OH (2024, 348 clinicians with data). Median for this group: 1,875. Middle half: 178 to 5,162.
Close to the middle for clinicians listed under Internal Medicine in Ohio (2024, 3,384 clinicians with data). Median for this group: 836. Middle half: 118 to 5,398.
Part D drug cost
Close to the middle for clinicians listed under Internal Medicine in Cincinnati, OH (2024, 348 clinicians with data). Median for this group: $154,518. Middle half: $9,369 to $414,544.
Close to the middle for clinicians listed under Internal Medicine in Ohio (2024, 3,384 clinicians with data). Median for this group: $69,804. Middle half: $3,586 to $436,236.
563 active clinicians are listed under Internal Medicine with a practice address in Cincinnati, OH (5,315 in Ohio).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Cincinnati
12.3% of these 563 clinicians have the CMS telehealth indicator.
58.6% of these 563 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 19% from 1,728 in 2020 to 1,400 in 2024.
- 2020: 1,728
- 2021: 1,238
- 2022: 1,374
- 2023: 1,317
- 2024: 1,400
-
30-day fills
30-day fills decreased 13% from 3,908 in 2020 to 3,408 in 2024.
- 2020: 3,908
- 2021: 3,030
- 2022: 3,275
- 2023: 3,245
- 2024: 3,408
-
Part D drug cost
Part D drug cost increased 16% from $116,907 in 2020 to $135,975 in 2024.
- 2020: $116,907
- 2021: $73,924
- 2022: $92,727
- 2023: $157,905
- 2024: $135,975
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 261% from $19,147.91 in 2021 to $69,178.49 in 2025.
- 2021: $19,147.91
- 2022: $30,995.71
- 2023: $46,948.34
- 2024: $34,891.76
- 2025: $69,178.49
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 104 records totaling $69,178.49.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $7,710.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Honoraria
Cash or cash equivalent
|
ANNOVERA | General | $6,000.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $6,000.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $6,000.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $4,800.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEXTSTELLIS | General | $3,600.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $3,600.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $3,600.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Veozah | General | $2,985.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Veozah | General | $2,175.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Lynkuet | General | $1,932.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $1,800.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $1,800.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BIJUVA | General | $1,800.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Grant
Cash or cash equivalent
|
— | General | $1,500.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Grant
Cash or cash equivalent
|
— | General | $1,500.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Travel and Lodging
In-kind items and services
|
BIJUVA | General | $1,297.44 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Veozah | General | $892.50 |
| Astellas Pharma US Inc |
Consulting Fee
Cash or cash equivalent
|
Veozah | General | $725.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Travel and Lodging
In-kind items and services
|
BIJUVA | General | $601.97 |
| MAYNE PHARMA COMMERCIAL LLC |
Honoraria
Cash or cash equivalent
|
BIJUVA | General | $600.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Veozah | General | $595.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Travel and Lodging
In-kind items and services
|
— | General | $492.97 |
| MAYNE PHARMA COMMERCIAL LLC |
Food and Beverage
Cash or cash equivalent
|
BIJUVA | General | $449.43 |
| MAYNE PHARMA COMMERCIAL LLC |
Food and Beverage
Cash or cash equivalent
|
BIJUVA | General | $402.50 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 110 | 9,525 | $1,964.12 | 36 |
| Losartan Potassium | Losartan Potassium | 99 | 7,409 | $1,082.23 | 26 |
| Metformin Hcl Er | Metformin Hcl | 88 | 7,710 | $1,200.96 | 29 |
| Levothyroxine Sodium | Levothyroxine Sodium | 69 | 6,060 | $729.02 | 20 |
| Atorvastatin Calcium | Atorvastatin Calcium | 53 | 4,770 | $700.71 | 15 |
| Alendronate Sodium | Alendronate Sodium | 44 | 3,695 | $666.10 | 19 |
| Lisinopril | Lisinopril | 43 | 3,770 | $254.80 | 14 |
| Amlodipine Besylate | Amlodipine Besylate | 39 | 2,849 | $183.75 | — |
| Gabapentin | Gabapentin | 35 | 2,450 | $967.77 | 12 |
| Bupropion Xl | Bupropion Hcl | 34 | 3,000 | $1,285.99 | 11 |
| Ezetimibe | Ezetimibe | 34 | 2,940 | $1,228.89 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 33 | 2,490 | $384.35 | — |
| Celecoxib | Celecoxib | 33 | 2,490 | $2,580.47 | 12 |
| Hydrochlorothiazide | Hydrochlorothiazide | 30 | 2,700 | $207.87 | — |
| Praluent Pen | Alirocumab | 30 | 840 | $14,302.21 | — |
| Meloxicam | Meloxicam | 29 | 1,770 | $146.98 | — |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | 2,340 | $375.56 | — |
| Omeprazole | Omeprazole | 22 | 1,980 | $227.28 | — |
| Metoprolol Succinate | Metoprolol Succinate | 21 | 1,870 | $171.88 | — |
| Repatha Sureclick | Evolocumab | 21 | 590 | $11,552.32 | — |
| Estradiol | Estradiol | 20 | 1,381 | $1,685.25 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 19 | 1,710 | $298.33 | — |
| Lorazepam | Lorazepam | 19 | 505 | $129.26 | — |
| Montelukast Sodium | Montelukast Sodium | 19 | 1,710 | $205.36 | — |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | 1,320 | $527.86 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Kentucky Rehabilitation Services, Inc.
580 Buttermilk Pike, Crescent Springs, KY 410171635
Phone: 8593416654
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Nurse Practitioner - Primary Care
Advanced Practice Registered Nurse
Internal Medicine
Doctor of Medicine (M.D.)
Nurse Practitioner
Certified Nurse Practitioner
Physician Assistant
Physician Assistant
Nurse Practitioner - Primary Care
Certified Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at 3908 MIAMI RD, CINCINNATI, OH 452273705 (Tel: 5137605511)
Registered at 3908 MIAMI RD, CINCINNATI, OH 452273705 (Tel: 5137605511)
Recorded as LISA LARKIN, MD.
Internal Medicine (license number reported to NPPES: OH 35061650L)
NPI status registered as active in NPPES database
Registered at 4460 RED BANK EXPRESSWAY, SUITE 100, CINCINNATI, OH 45227 (Tel: 5132715111)
Registered at 2830 VICTORY PKWY, CINCINNATI, OH 452061785 (Tel: 5132453600)
Recorded as LISA LARKIN, MD.
Internal Medicine (license number reported to NPPES: OH 35061650L)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Cincinnati
- Dr. Dorothy Shaffer, MD
- Dr. Erin Baldos, MD
- Dr. Christine Burrows, MD
- Jonathan Goldberg
- Dr. Bradley Beckham, MD
- Dr. Clifford Mowery, MD
Mailing Address
3908 Miami Rd
Cincinnati, OH 452273705
Phone: 5137605511